Temasek, HighLight Capital invest $210m in China’s VIVA Biotech 

Temasek, HighLight Capital invest $210m in China’s VIVA Biotech 

Photo by Louis Reed on Unsplash

Simran Vaswani

21 November, 2023

Edited by: Padma Priya

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.